Compounders Research Compare

Sintx Technologies, Inc.(SINT)

Medical - Devices · Salt Lake City, UT

$2.18Daily change unavailable

Delayed quote: Oct 6, 2026, 3:50 PM EDT

About Sintx Technologies, Inc.

Sintx Technologies, Inc. is an advanced materials enterprise dedicated to researching, developing, and commercializing medical devices crafted from silicon nitride. These innovative products serve biomedical, industrial, and antipathogenic uses, primarily marketed across the United States. Its diverse portfolio includes solid and porous silicon nitride, silicon nitride powder, and specialized coating products, along with advanced silicon nitride composite materials and polyetherketoneketone. Established in 1996, this company, once known as Amedica Corporation, has its corporate headquarters situated in Salt Lake City, Utah.

Salt Lake City, UT

32 employees

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Eric K. Olson

View full financials

EV/FCF Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/FCF ratio is N/A as of 2026-10-06T19:53:57.070Z.

Stored calculation inputs

Calculation as of: 2026-10-06T19:53:57.070Z.

Quote observation: 2026-10-06T19:50:20.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 13,859,631
Total debt · period ending 2026-06-30: 3,049,000
Cash · period ending 2026-06-30: 3,590,000
TTM free cash flow · period ending 2026-06-30: -10,336,000

FMP input reference: e88a9ce363f502b6754b19b8a4115a17c58c771a6bc05fe10e5aff55a47e2c9d

Free Cash Flow|FCF Yield|P/FCF Ratio|EV/EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

SINT EV/FCF Ratio Metrics

EV/FCF RATIO

N/A

SINT Competitors' EV/FCF Ratio

Sintx Technologies, Inc.

Current

Market Cap

$13.86M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Pulsenmore Ltd. Ordinary Shares

Market Cap

$14.17M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Obsidian Therapeutics Inc.

Market Cap

$13.93M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Vyome Holdings, Inc.

Market Cap

$14.39M

EV/FCF Ratio

12.43x

TTM Avg

13.15x

3Y Avg

13.15x

5Y Avg

13.15x

Optimi Health Corp.

Market Cap

$13.36M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Citius Pharmaceuticals, Inc.

Market Cap

$13.31M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Karyopharm Therapeutics Inc.

Market Cap

$14.86M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IN8bio, Inc.

Market Cap

$13.14M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Pasithea Therapeutics Corp.

Market Cap

$14.87M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Passage Bio, Inc.

Market Cap

$12.77M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
Sintx Technologies, Inc. (SINT)	$13.86M	N/A	N/A	N/A	N/A
Pulsenmore Ltd. Ordinary Shares (PLSM)vs ›	$14.17M	N/A	N/A	N/A	N/A
Obsidian Therapeutics Inc. (OBX)vs ›	$13.93M	N/A	N/A	N/A	N/A
Vyome Holdings, Inc. (HIND)vs ›	$14.39M	12.43x	13.15x	13.15x	13.15x
Optimi Health Corp. (OPTH)vs ›	$13.36M	N/A	N/A	N/A	N/A
Citius Pharmaceuticals, Inc. (CTXR)vs ›	$13.31M	N/A	N/A	N/A	N/A
Karyopharm Therapeutics Inc. (KPTI)vs ›	$14.86M	N/A	N/A	N/A	N/A
IN8bio, Inc. (INAB)vs ›	$13.14M	N/A	N/A	N/A	N/A
Pasithea Therapeutics Corp. (KTTA)vs ›	$14.87M	N/A	N/A	N/A	N/A
Passage Bio, Inc. (PASG)vs ›	$12.77M	N/A	N/A	N/A	N/A

Cash Flow Valuation Comparison

EV/FCF

N/A

P/FCF

N/A

FCF Yield

N/A

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

EV/FCF accounts for debt and cash through enterprise value
P/FCF only considers equity value
EV/FCF can be compared across companies with different debt levels
Both measure how the market values cash generation

EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

Free Cash Flow FCF Yield P/FCF Ratio EV/EBITDA All Metrics